Table 3 Associations between clinical characteristics and circulating lncRNAs in patients with well-controlled type 2 diabetes.
LIPCAR | uc004cos.4 | uc004cov.4 | uc004coz.1 | uc011mfi.2 | uc022bqu.1 | uc022bqw.1 | MIAT | SENCR | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
β | P-value | β | P-value | β | P-value | β | P-value | β | P-value | β | P-value | β | P-value | β | P-value | β | P-value | |
Age | 0.372 | 0.010* | 0.380 | 0.009* | 0.304 | 0.040* | 0.239 | 0.106 | 0.184 | 0.210 | 0.277 | 0.060 | 0.370 | 0.011* | 0.165 | 0.261 | 0.162 | 0.271 |
Time since diagnosis of diabetes | 0.373 | 0.010* | 0.407 | 0.005* | 0.375 | 0.010* | 0.347 | 0.017* | 0.289 | 0.047* | 0.319 | 0.029* | 0.301 | 0.040* | −0.071 | 0.633 | 0.190 | 0.195 |
BMI | −0.448 | 0.002* | −0.380 | 0.009* | −0.434 | 0.003* | −0.360 | 0.013* | −0.416 | 0.003* | −0.409 | 0.004* | −0.438 | 0.002* | −0.161 | 0.276 | 0.012 | 0.934 |
Waist circumference | −0.459 | 0.001* | −0.431 | 0.003* | −0.483 | 0.001* | −0.429 | 0.003* | −0.469 | 0.001* | −0.448 | 0.002* | -0.458 | 0.001* | −0.205 | 0.162 | −0.001 | 0.995 |
Subcutaneous fat volume | −0.491 | <0.001* | −0.416 | 0.004* | −0.453 | 0.002* | −0.404 | 0.005* | −0.462 | 0.001* | −0.453 | 0.001* | −0.468 | 0.001* | −0.168 | 0.255 | −0.024 | 0.874 |
Plasma fasting insulin | −0.548 | <0.001* | −0.468 | 0.001* | −0.472 | 0.001* | −0.441 | 0.002* | −0.527 | <0.001* | −0.475 | 0.001* | −0.499 | <0.001* | −0.165 | 0.268 | 0.067 | 0.654 |
HDL cholesterol | 0.441 | 0.002* | 0.337 | 0.023* | 0.314 | 0.036* | 0.299 | 0.043* | 0.377 | 0.009* | 0.342 | 0.020* | 0.347 | 0.018* | 0.122 | 0.413 | −0.090 | 0.547 |
us−CRP | −0.307 | 0.038* | −0.271 | 0.071 | −0.297 | 0.048* | −0.245 | 0.100 | −0.317 | 0.030* | −0.334 | 0.023* | −0.308 | 0.037* | −0.148 | 0.321 | −0.031 | 0.834 |